New AMA policy calls for med students getting hands-on EHR training

The American Medical Association (AMA) has adopted a policy to ensure medical students receive necessary hands-on clinical experience using EHR.

“There is a clear need for medical students today to have access to and learn how to properly use electronic health records well before they enter practice,” said AMA Board Member Jesse M. Ehrenfeld, MD, in a release. “For our future physicians to successfully navigate the 21st century healthcare system, we must close the gaps that currently exist between how medical students are educated and how health care is delivered now and in the future.”

The new policy calls on the AMA to work with medical school accrediting bodies to encourage the nation’s medical schools, along with residency and fellowship training programs, to teach students how to use electronic devices in the exam room and at the bedside. The policy also encourages the AMA to support medical student acquisition of hands-on experience in documenting patient encounters and entering clinical orders into patients’ EHRs, with appropriate supervision.

As part of the AMA’s Accelerating Change in Medical Education initiative aimed at reshaping medical education in the U.S., AMA work currently is underway along with a consortium of 11 leading medical schools to develop innovative models that incorporate EHR training into undergraduate medical education. The future goal is a plan for an ideal software system that should be used at medical schools and teaching hospitals that offer teaching EHRs.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.